Announcements

  • Legislative victories for sugar-sweetened beverage bills

    Despite intense lobbying efforts by the soda industry, two bills that aim to reduce consumption of sugar-sweetened beverages that contribute to obesity, diabetes, tooth decay and heart disease have advanced in the Legislature. A CDA co-sponsored bill to end manufacturer discounts by SSB companies and a bill to require warning labels on sugar-sweetened beverages passed their first committee. A bill to enact a tax on sugar-sweetened beverages also passed in committee but has since been held. Assemblymember Jim Wood, DDS, (D-Santa Rosa) provided a strong message about the need for action to reduce consumption of sugar-sweetened beverages. Watch here.
  • CDA Leadership application available online

    The application for available volunteer leadership positions on CDA councils, committees and boards is online at cda.org/leadership. CDA is seeking qualified applicants for at-large positions on the Leadership Development Committee, the Judicial Council and the Council on Peer Review, as well as for the new dentist position on the CDA Presents Board of Managers. CDA is also accepting applications for secretary. Job descriptions for all councils, committees and boards are available at cda.org/leadership. Applications will be accepted until May 31 (no late applications accepted).

    Please contact volunteer@cda.org with questions.
  • CDA Presents Anaheim is May 16-18, 2019

    This spring, CDA Presents will offer 175+ C.E. lectures and workshops, innovative tools from 550+ exhibitors and countless opportunities for dental professionals to network with their peers, colleagues and mentors. Attendees can join in new courses to expand their skills and enhance their expertise:

    • Insights on new restorative techniques and materials through an interactive panel discussion led by leaders in the field
    • Live-patient demonstration feeds of chairside CAD/CAM restoration and guided implant placement treatments
    • Participation in a dental malpractice mock trial to better understand what could happen in court
    • Sexual harassment training for the entire dental team to meet new state requirements for employers
    To learn more and register, go to www.cdapresents.com.

    Don't forget to register for our OCDS Members' Hospitality Suite!
  • Volunteer hosts needed for ADA/FDI 2019 conference in San Francisco

    The San Francisco ADA Committee on Local Arrangements Team is looking for volunteer room hosts and speaker hosts for the upcoming ADA/FDI conference in San Francisco on September 4-8, 2019.

    Although this year's registration is free, all courses have a fee. If you host, you do not have to pay for that course. You are asked to volunteer for 3-4 assignments or an equivalent of 1 full day. We would like to encourage you to take advantage of this opportunity by entering the volunteer code: CLACDA when completing your registration and volunteering for hosting assignments.

    Please click here to register.


  • ADA Statement on Study Involving Dental Floss

    January 14, 2019

    CHICAGO — Recent, wide-spread news coverage based upon a recent research study may raise unwarranted concern about the safety of certain types of dental floss. The ADA Science Institute finds the data insufficient to support the conclusions presented in this research and associated media coverage.  

    No restrictions on the use of dental floss have been issued by the U.S. Food and Drug Administration, the regulatory agency that oversees clearance of dental products marketed to the public. It is also important to bear in mind that this is a single study. Public health policy and safety decisions should be based on the collective weight of scientific evidence.

    The study, published in the Journal of Exposure Science & Environmental Epidemiology, involves a small sample of 178 women and their self-reported use of a wide array of consumer products and foods. 

    The study measured blood samples from 178 women and found that those who reported using a certain brand of dental floss had higher levels of a type of PFAS called PFHxS (perfluorohexanesulfonic acid) than those who didn't. 

    One of many shortcomings of this study, according to the ADA Science Institute, is that the study measured fluorine as a marker of PTFE (polytetrafluoroethylene), though the women in the study who reported using a particular brand of floss were found to have elevated levels of PFHxS. 

    PTFE is often used in food and beverage, pharmaceutical, and cosmetic applications. The fact that the researchers were able to find the PTFE marker in several brands of floss does not mean that it is the source of the PFHxS in the women.  

    Given that this was a retrospective study including self-reported use of products, there are likely many other differences between women who did and did not report having used the brand of floss mentioned.

    The ADA sees no cause for concern based on current evidence, and above all continues to encourage people to clean between their teeth daily with floss or other interdental cleaner as part of the ADA’s daily oral hygiene recommendations.
  • CDT 2019: Spend less time on coding, more time with patients.


    Get back your quality time with the new CDT 2019 and Companion Kit! This essential ADA resource helps your team code more accurately – which speeds claim processing, lessens the need for additional information requests, and reduces claim rejections.

    This CDT 2019 Kit includes:

    • CDT 2019: Dental Procedure Codes has all the new and updated codes, including 15 new codes, 5 revised codes and 4 deleted codes, PLUS complete descriptors.
    • CDT 2019 Coding Companion trains staff on how to use the right codes at the right time. The book features four new authors, 35 new coding scenarios, 21 new Q&A, and a new chapter on working with dental benefit plans.
    CDT 2019 and Companion Kit
    Member Price: $85.00 / Retail Price: $127.50
    Free e-Books now included when you order directly from ADA Catalog!

    Order now! Visit ADAcatalog.org or call 800.947.4746 from 7 a.m. to 6 p.m. CT.

    Use promo code 18456BE by 11/23/2018 to Save 15% on all ADA Catalog products.
  • New opioid laws will affect dentistry in 2019 and beyond

    Many bills were introduced over the past year to combat the opioid epidemic in California, as CDA previously reported. Here is an overview of the CDA-supported legislation signed into law by Gov. Jerry Brown in September and how these bills will affect the practice of dentistry.

    AB 2789 (Wood-Healdsburg) E-prescribing

    Beginning Jan. 1, 2022, health care practitioners authorized to issue all controlled and noncontrolled prescriptions are mandated by this law to have the capability to transmit prescriptions electronically. Pharmacies are required by this law to have the ability to receive these electronic transmissions.

    Specified exemptions to this law include temporary technological or electrical failure or when the practitioner reasonably determined that it would be impractical for the patient to obtain the substances prescribed by an e-prescription in a timely manner when the delay would impact the patient’s medical condition. In the case that an electronic transmission to a pharmacy cannot be completed, the prescription must be electronically issued directly to the patient. 

    This new law will help reduce prescription fraud, including the abuse of opioids, and adverse events caused by handwriting errors. The nearly three-year implementation time frame gives dentists and other health care practitioners ample time to obtain adequate e-prescribing systems, to train staff and to update office workflow protocols.

    SB 1109 (Bates-Laguna Niguel) Informed Consent for Minors

    The Dental Board of California is allowed by this law to include the risks of addiction associated with the use of Schedule II drugs in mandatory continuing education requirements. The dental board has already begun discussions about what these continuing education requirements might look like. CDA has been and will continue to be engaged in this stakeholder process.

    Additionally, beginning Jan. 1, 2019, this bill requires a prescriber to discuss the following with a minor or the minor’s parent or guardian before issuing the first opioid prescription in a single course of treatment:

    1. The risks of addiction and overdose associated with the use of opioids.
    2. The increased risk of addiction to an opioid to an individual suffering from both mental and substance-abuse disorders.
    3. The danger of taking an opioid with benzodiazepine, alcohol or another central nervous system depressant.  
    CDA Practice Support and The Dentists Insurance Company are developing for members a resource that consists of a sample discussion script. CDA will publish more details about the script when it becomes available in November.

    AB 2086 (Gallagher-Yuba City) CURES Prescriber Report

    This law allows a prescriber to access the CURES database and generate a report that lists patients for whom he or she is listed as a prescriber in the CURES database. Once the system upgrades allow reports to be generated, prescribers will be able to more easily review their prescribing history and to detect potential red flags or prescriptions for which they have been falsely named the prescriber. While no official timeline has been set, CDA will keep members updated as to when the CURES database functionality is updated to reflect this new feature.

    AB 1751 (Low-Campbell) Interstate CURES Access Agreement

    This law authorizes the Department of Justice to put in place regulations by July 1, 2020, for the purpose of entering into agreements with other states to share prescription drug monitoring program information in compliance with California laws relating to patient privacy and data security standards.
    Once implemented, the new law will help provide prescribers with a more complete prescription history if patients receive prescriptions in multiple states and will help curb “doctor shopping” in communities near California’s borders. 

    AB 1753 (Low-Campbell) Controlled-Substance Prescription Pad Requirements

    This law requires controlled-substance prescription-pad manufacturers approved by the Department of Justice to have uniquely serialized numbers in a manner prescribed by the department. This new law will help curb controlled-substance prescription fraud. CDA will keep members updated on changes to the approved controlled-substance prescription-pad vendor list.

    For more news and resources on opioids and CURES, visit cda.org/opioid. CDA will continue to inform members about the requirements of these new laws as they take effect.
  • Legislative victory: Dental Plan Transparency Act passes

    Gov. Brown also signs bill that adds training requirements for pediatric dental sedation

    CDA’s sponsored legislation calling for more value and transparency from dental plans passed the California Legislature with bipartisan support and was signed by Gov. Jerry Brown on Sept. 29. CDA and the author of SB 1008, Sen. Nancy Skinner (D-Berkeley), worked closely with stakeholders to ensure the best outcome for CDA members and consumers in California — increased transparency, accountability and value from dental benefit plans.

    “Signing this bill into law is an unqualified victory for dental plan patients in California. Patients deserve to have clear, understandable information about their dental plans,” said CDA President Natasha Lee, DDS. “As providers, we all too often see patients in our offices struggle to understand what procedures are and are not covered. We aim to stop that and ensure patients get the care they need with SB 1008.”

    Dr. Lee continued: “I want to thank Gov. Brown for signing SB 1008 and state Sen. Skinner for working with her colleagues to pass this important reform.”

    SB 1008 builds off CDA-sponsored legislation that passed in 2014, AB 1962 (Skinner), which created a mandate for dental plans to annually disclose to state regulators and the public their “loss ratio,” or how much of premium dollars are spent on patient care. Three years of reporting shows a wide variation in dental loss ratios (DLR) by product type and market, with some plans falling as low as 4 percent. This variation raises significant questions about the consistency and value of many dental plans. The plan-reported data validates the concern that too much of dental plan premiums are spent on administrative overhead costs and not enough are spent on patient care.

    The lack of standardization among dental plans and a regulatory “Wild West” lead to questionable plan value and consumer frustration when needed services are not covered. To help combat this, SB 1008 will require all dental plans to use a uniform matrix to disclose their benefits, similar to the matrix used by medical plans. The matrix will provide plan beneficiaries with a uniform summary of benefits and coverage template to include plan details, including: deductible; annual benefit limit; coverage of the following categories: preventive and diagnostic services, basic and major services, and orthodontia; reimbursement levels and estimated enrollee cost share; waiting periods; and examples to illustrate coverage of commonly used benefits. The uniform matrix will be designed through a stakeholder process to be available starting in 2021 or 12 months after regulations are adopted.

    Sen. Skinner said, “No one should have to drill into 80 pages of legalese to understand their dental plan. SB 1008 requires dental insurers to provide details on what their plans cover in a simple, easy to understand format, so consumers understand what services are covered and what services they may have to pay for out of pocket.” 

    SB 1008 will help level the playing field for consumers and providers by holding plans accountable to comparable disclosure standards as medical plans. While amendments were taken along the way, CDA is pleased that the new law continues the association’s efforts to increase dental plan transparency and accountability.

    SB 501 passes, adds training, monitoring requirements for pediatric dental sedation

    Gov. Brown also signed into law SB 501, authored by Sen. Steve Glazer (D-Orinda), which updates the regulatory structure for pediatric dental sedation and ensures that children have access to safe, effective pediatric sedation services when needed.

    SB 501 reflects three years of work, starting with a 2016 report from the Dental Board of California that studied recent pediatric deaths and made recommendations to improve safety. SB 501 updates definitions for levels of sedation to reflect those recognized by the American Dental Association, acknowledging that level of sedation is independent from route of administration.

    Developed through substantial stakeholder involvement, SB 501 provides for additional training and monitoring requirements targeted to ensure that during the provision of pediatric dental sedation, the right people are in the room with the training and ability to respond quickly and expertly to emergencies should they arise.

    Gov. Brown vetoes SDF legislation

    Lastly, another CDA-sponsored bill, SB 1148 authored by Sen. Richard Pan, MD, (D-Sacramento) was vetoed. This bill would have made silver diamine fluoride a covered benefit in the Medi-Cal dental program for young children, the developmentally delayed, and adults residing in living facilities. Gov. Brown issued a message on this bill saying that because it would have required new ongoing state funding, he believes it should be considered as part of the budget.

    CDA will update members about the provisions of SB 1008, including the new uniform matrix to be used by dental plans, once they are developed.
  • FDA Approves HPV Vaccine For Men And Women Aged 27 To 45

    The New York Times (10/5, Grady, Hoffman) reported that the Food and Drug Administration has approved the HPV vaccine “for men and women from 27 to 45-years-old.” The article noted that the vaccine “had been previously approved for minors and people up to age 26.” The HPV vaccine “works against the human papillomavirus, HPV, which can also cause genital warts and cancers” including “tumors affecting part of the throat – called oropharyngeal cancers” which are on the rise.

    CNN (10/5, Lamotte) reported that Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said, “HPV vaccination prior to becoming infected with the HPV types covered by the vaccine has the potential to prevent more than 90 percent of these cancers, or 31,200 cases every year, from ever developing.”

    The Washington Post (10/5, McGinley) reported that the approval “represents an important opportunity to help prevent HPV-related diseases and cancers in a broader age range,” said Dr. Marks.

    Dentists can refer patients to MouthHealthy.org for information on oral cancer and HPV and oropharyngeal cancer, and JADA For the Patient includes the article Oral cancer: What to do if something unusual shows up. The ADA also offers the brochure “Get The Facts About Mouth and Throat Cancer.”
  • CURES and Opioid Pain Management

    All dentists who are authorized to prescribe, order, administer, furnish or dispense controlled substances were required to register in the Controlled Substance Utilization Review and Evaluation System (CURES) by July 1, 2016, and must now have updated browsers to access the system. Dispensed controlled substance prescriptions are recorded in CURES, which allows prescribers to look up a patient's controlled substance current usage and past history.
  • Controlled Substance Utilization Review and Evaluation System

    California’s Prescription Drug Monitoring Program
    CURES 2.0 (Controlled Substance Utilization Review and Evaluation System) is a database of Schedule II, III and IV controlled substance prescriptions dispensed in California serving the public health, regulatory oversight agencies, and law enforcement. CURES 2.0 is committed to the reduction of prescription drug abuse and diversion without affecting legitimate medical practice or patient care.

    The Health Insurance Portability and Accountability Act of 1996 (HIPAA) and confidentiality and disclosure provisions of California law cover the information contained in CURES 2.0.

    Access to CURES 2.0 is limited to licensed prescribers and licensed pharmacists strictly for patients in their direct care; and regulatory board staff and law enforcement personnel for official oversight or investigatory purposes.

    CURES Registration Requirements
    California law (Health and Safety Code Section 11165.1) requires all California licensed prescribers authorized to prescribe scheduled drugs to register for access to CURES 2.0 by July 1, 2016 or upon issuance of a Drug Enforcement Administration Controlled Substance Registration Certificate, whichever occurs later. California licensed pharmacists must register for access to CURES 2.0 by July 1, 2016, or upon issuance of a Board of Pharmacy Pharmacist License, whichever occurs later.

    Prescriber and dispenser registration to access CURES 2.0 is simple and fully automated. Prescribers and dispensers can register to access CURES by clicking here.
  • Dental Amalgam Control Program FAQ

    What is the Environmental Protection Agency’s Dental Office Point Source Category?

    The Environmental Protection Agency’s (EPA) Dental Office Point Source Category is a new regulatory program consisting of Pretreatment Standards, best management practices (BMPs), and other requirements meant to reduce discharges of mercury and other metals from dental offices into municipal sewerage treatment plants known as publicly owned treatment works (POTWs).

    What is the regulatory basis for this new program?

    The Clean Water Act, passed in 1972, established the National Pretreatment Program (NPP) to address indirect discharges from industries to publicly owned treatment works (POTWs).  The NPP, published in 40 CFR Part 403, provides the regulatory basis to require nondomestic dischargers to comply with Pretreatment Standards to ensure that the goals of the Clean Water Act (CWA) are attained.

    What is a Publicly Owned Treatment Works?

    Publicly owned treatment works (POTWs) collect wastewater from homes, commercial buildings, and industrial facilities and transport it via a series of pipes, known as a collection system, to the treatment plant(s).  The treatment plant then removes harmful organisms and other contaminants from the sewage so the wastewater can be discharged safely into a receiving stream.  Without treatment, sewage creates bad odors; contaminates rivers, lakes, and water supplies; and spreads disease.  POTWs are designed to treat typical household waste, biodegradable commercial waste, and biodegradable industrial waste, however, the treatment plants are neither designed for nor able to remove toxic or non-conventional pollutants that commercial and industrial facilities discharge.

    Who will enforce these new regulations?

    Unlike other environmental programs that rely on federal or state governments to implement and enforce specific requirements, under the NPP, most of the responsibility rests on local municipalities.  In general, all large POTWs are required to establish a local pretreatment program and must enforce all national pretreatment standards and requirements in addition to any more stringent local requirements necessary to protect the site-specific conditions of their treatment processes.  Consequently, a POTW with an approved pretreatment program is the Control Authority.

    In central and north Orange County, that local municipality is the Orange County Sanitation District (OCSD).  OCSD is a special district, a separate local government that delivers a limited public service (sewerage collection and treatment) to a limited geographical area.  Special districts are instrumental in localizing the costs and benefits of public services.  Initially formed in 1954 to take over wastewater treatment from its member city predecessors, OCSD is now entering its 64th year of protecting public health and the environment by providing effective wastewater collection, treatment, and recycling.

    Who is affected?

    The new Dental Office Point Source categorical regulations apply to wastewater discharges to POTWs from offices where the practice of dentistry is performed including large institutions such as dental schools and clinics; permanent or temporary offices, home offices; and dental offices owned and operated by federal, state, or local governments including military bases. 

    The EPA’s final rule includes a provision to significantly reduce and streamline the General Pretreatment Regulations for the dental offices, a.k.a. Dental Dischargers.  To simplify implementation of these regulations, the EPA has established that Dental Dischargers are not Significant Industrial Users or Categorical Industrial Users unless designated such by their Control Authority.  This regulatory approach eliminated many General Pretreatment Program requirements that that would have otherwise applied.

    What must Dental Offices do to comply with the new Dental Office Point Source categorical regulations?

    All Dental Dischargers must submit a Compliance Report to their Control Authority.  Dental dischargers that place or remove amalgam must also operate and maintain an amalgam separator, and must not discharge scrap amalgam or use certain kinds of line cleaners as detailed below.

    The program requires dental dischargers that place or remove amalgam to use technology-based pretreatment such as an amalgam separator (pretreatment is a term that refers to treating wastewater before discharge to a POTW), and to implement two BMPs:

    Waste amalgam including, but not limited to, dental amalgam from chairside traps, screens, vacuum pump filters, dental tools, cuspidors, or collection devices, must not be discharged to a POTW, and
    Dental unit water lines, chair-side traps, and vacuum lines that discharge amalgam process wastewater to a POTW must not be cleaned with oxidizing or acidic cleaners, including but not limited to bleach, chlorine, iodine and peroxide that have a pH lower than 6 or greater than 8.
    The Dental Discharger must also maintain records of various activities as defined in the Dental Office Point Source regulations.

    Are there exemptions?

    Yes, Dental Dischargers that do not place dental amalgam, and do not remove dental amalgam except in limited emergency or unplanned, unanticipated circumstances are exempt from any further requirements of the rule program provided they certify such in their Compliance Report to the Control Authority (OCSD).

    Dental dischargers that exclusively practice one or more of the following dental specialties:

    Oral Pathology,
    Oral & Maxillofacial Radiology,
    Oral and Maxillofacial Surgery,
    Orthodontics,
    Periodontics, or
    Prosthodontics
     

    and do not engage in the practice of amalgam restorations or removals, and therefore do not have any wastewater discharges containing dental amalgam should download the Limited Dental Discharger Compliance Report from OCSD’s website.  These regulations do not currently apply to Dental Mobile Units.

    What are the deadlines for compliance?

                New Dental Offices

    The compliance date for new dental offices ("New Sources") is the effective date of the rule, July 14, 2017.  New sources must immediately comply with all requirements of the Dental Office Point Source Category, and submit a Compliance Report to the Control Authority no later than 90 days following the introduction of wastewater into a POTW.  (New Source does not include an ownership change.)

                Existing Dental Offices

    The effective date of the rule is July 14, 2017.

    Existing dental offices must comply by July 14, 2020, and must submit a Compliance Report to the Control Authority no later than October 12, 2020.

                •  Existing amalgam separators may be operated for their lifetime or ten years, whichever comes first.

                •  When a separator needs replacement, or the ten-year period has ended and the separator does not meet the standard of the final rule, a dental office must replace it with one that meets the requirements of the final rule.

                Following Ownership Transfer

    For existing sources, the new owner must submit a new Compliance Report to the Control Authority no later than 90 days after the transfer of ownership.

    Who must follow the Best Management Practices (BMPs)?

    All dental practitioners must comply with the BMPs, including the dentists, hygienists, and any other personnel in the practice or clinic, when said individuals handle dental amalgam, or amalgam derived waste.   Train the appropriate staff in the manufacturer’s recommended operating and maintenance procedures for the amalgam separator; the proper handling, management, and disposal of amalgam materials and wastes; and the correct methods for cleaning chair-side traps, vacuum lines, and dental tools. The EPA suggests dental offices consider use of signs displayed prominently in the office or electronic calendar alerts to remind staff of dates to perform and document routine maintenance and inspections.  It is also recommended that the dental office maintain a log to demonstrate compliance with the BMP training activities. 

    Who is responsible for completing and submitting the Compliance Report Form?

    All operator/proprietor, a practitioner/owner, or the general partners must complete the “Dental Discharger Compliance Report” form for each dental office location.

    An Exempt Dental Discharger, a dental office that has eliminated the use of dental amalgam and only expects to remove amalgam to provide immediate treatment, must complete the “Limited Dental Discharger Compliance Report” form.

    Who must sign the Compliance Report Form?

    Per 40 CFR 441.50(a)(2), the Compliance Report must be signed and certified by a responsible corporate officer, a general partner or proprietor if the dental facility is a partnership or sole proprietorship, or a duly authorized representative in accordance with the requirements of 40 CFR 403.12(l).

                Responsible Corporate Officer (Authorized Representative)

    a)         If the applicant or User is a corporation:

    (1)        The president, secretary, treasurer, or a vice president of the corporation in charge of a principal business function, or any other person who performs similar policy or decision-making functions for the corporation; or

    (2)        The manager of one or more manufacturing, production, or operation facilities, provided the manager is authorized to make management decisions that govern the operation of the regulated facility including having the explicit or implicit duty of making major capital investment recommendations, and initiate and direct other comprehensive measures to assure long-term environmental compliance with environmental laws and regulations; can ensure that the necessary systems are established or actions taken to gather complete and accurate information for individual Wastewater discharge permit requirements; and where authority to sign documents has been assigned or delegated to the manager in accordance with corporate procedures.

    b)         If the applicant or User is a partnership or sole proprietorship: a general partner or proprietor, respectively.

    c)         If the applicant or User is a federal, state, or local governmental facility: a director or highest official appointed or designated to oversee the operation and performance of the activities of the government facility, or the designee.

                Duly Authorized Representative (Designated Representative*)

    d)         The individuals described in paragraphs (a) through (c) above, as Responsible Officers, may designate an Authorized Representative if the authorization is in writing, the authorization specifies the individual or position responsible for the overall operation of the facility from which the discharge originates or having overall responsibility for environmental matters for the company or organization, and the written authorization is submitted to OCSD.

    e)         An applicant or User not falling within one of the above categories must designate as the Responsible Officer an individual responsible for the overall operation of the facility. The Responsible Officer may designate an Authorized Representative.  (If signed by a duly authorized representative, the Certification must be accompanied by a completed and signed designated signatory form.)  

    * All correspondence regarding all permit and enforcement issues shall be sent to the Designated Signatory.  It is the Designated Signatory’s responsibility to keep the Responsible Officer informed at all times regarding all permit and enforcement issues.  The Responsible Officer remains legally responsible for all wastewater discharge to the sewer from this facility and for ensuring that he is duly informed by the Designated Signatory. 

    How often does the Compliance Report Form need to be submitted?

    In general, only once.  However, a new Certification should be submitted if there is a change in the following:

    Name, location, or ownership interest in the dental practice or clinic, or
    Change in the amalgam separation equipment.
    Do I need to retain a copy of the completed Compliance Report Form?

    Yes.  Per 40 CFR 441.50(a)(5), as long as a Dental facility subject to this part is in operation, or until ownership is transferred, the Dental facility or an agent or representative of the dental facility must maintain this One Time Compliance Report and make it available for inspection in either physical or electronic form.

    Are Dental Dischargers required to submit the Compliance Report in both hard copy and electronic formats?

    Yes.  To ensure Dental facilities only need to mail the report one time, OCSD would like to review the Compliance Report for completeness and accuracy before the hard copy is sent.  Please E-mail the completed electronic file to OCSD before submitting the hard copy of the completed form by post.  OCSD will reply to your E-mail confirming the report’s completeness or reply with suggestions for any deficiencies noted.  Finally, Dental facilities must submit a hard copy original with a “Live Signature” to satisfy the EPA’s requirements.

    How do I submit the Compliance Report Form?
    • E-mail Electronic Adobe PDF dentaloffice@ocsd.com
    • Mail Hard Copy with Live Signature
      Orange County Sanitation District
      10844 Ellis Avenue
      Fountain Valley, CA 92708-7018
      Attn:  Merrill Seiler, Div. 620 

      Who can I call for assistance with completing the Compliance Report Form, or if there are additional questions?

      Merrill Seiler, Principal Environmental Specialist
      Office: (714) 593-7436
      E-mail:  dentaloffice@ocsd.com

  • Deadline July 14, 2020: Don’t Be In Violation Of The Clean Water Act

    The Environmental Protection Agency’s Dental Office Point Source Category, effective July 14, 2017, requires Dental facilities without amalgam separators to install amalgam separators and submit a One-Time Compliance Report to the local control authority by July 14, 2020 (some exceptions apply). Brand new practices must immediately comply with the amalgam separator requirement, and practices with amalgam separators installed on June 14, 2017 have until June 14, 2027 to change their separators.

    Dental offices in central and north Orange County may download the Compliance Report forms and obtain additional information on complying with this regulation at www.ocsd.com (click the “Dental Office Point Source Category” link under the Businesses tab), or by contacting Merrill Seiler at the Orange County Sanitation District (714-593-7436 or DentalOffice@ocsd.com). Refer to the EPA’s Frequently Asked Questions on the Dental Office Category Rule for more information.